Press Release

Navvisa Names Gary Yeamans as Chief Growth Officer

Issued by Navvisa

Oct. 27, 2022

Accomplished Sales Leader with Track Record Driving Innovation in Employee Benefits Will Lead Response to Increasing Demand for Cancer Care Solutions

WOODSIDE, CA – Navvisa, a leader in cancer care guidance for employees, today announced that Gary Yeamans will oversee the growth strategy as the company continues to add top talent to drive innovation and support patients and family caregivers who are facing a cancer diagnosis. In this role, Yeamans will grow Navvisa’s business across employer, payer, and benefit consultant segments, broadening the reach of Navissa’s cancer care services.

Yeamans comes to Navvisa with more than 14 years leadership experience at Advance Medical as EVP of Growth and Marketing. Advance Medical was one of the largest global virtual care providers offering patient-centric expert medical opinions for many conditions, including cancer. Gary grew the North American business to include multiple large enterprise customers, such as Apple, Google, eBay, Fidelity Investments, and GE.  Advance Medical was ultimately acquired by Teladoc.

“Gary is an exceptional leader with decades of go-to-market experience and a track record of driving rapid growth,” said Vanessa Johnson, CEO. “His deep knowledge of the healthcare and benefits landscape will accelerate Navvisa’s ability to bring every cancer patient and family caregiver a trusted, expert partner by their side as they navigate the complexities of a cancer diagnosis.”

“I’m passionate about the intersection between strategy and innovation and how it can foster better clinical outcomes and—ultimately—a better consumer experience,” said Yeamans. “With the clinical expertise that Vanessa and her team have brought together, it’s clear that Navvisa is uniquely positioned to impact one of the largest healthcare costs employers face while reducing friction within the ecosystem. It’s rare to see, and I’m thrilled to be a part of the team.”

About Navissa

Navvisa, Inc., is a privately held company with a mission to transform oncology care and the cancer patient experience by combining digital technology with personalized guidance. Founded in January 2021, and a graduate of the Alchemist Accelerator, Navissa provides employees with a personal cancer care nurse via telehealth to guide them throughout their cancer journey. Certified oncology nurses improve outcomes for both patients and caregivers, keep employees engaged and productive at work, reduce costs of care, and become a trusted partner that helps employees move forward with confidence. Learn more at: https://navvisa.com.

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.